Optiject (Ioversol)

Optiject is a low‑osmolality iodine‑based contrast agent used in radiographic examinations that require enhanced vascular and organ delineation.

• X‑ray angiography: improves visualization of blood vessels and helps detect stenoses or occlusions.
• Computed tomography (CT) scanning: provides high‑contrast images of abdominal, thoracic and cerebral structures.
• Intravenous urography: enhances delineation of the urinary collecting system for diagnostic assessment.
• Myelography: facilitates clear imaging of the spinal canal and nerve roots.
• Endovascular interventions: aids in real‑time guidance of catheter‑based procedures.

• Ioversol is a water‑soluble, non‑ionic iodine compound that transiently increases the attenuation of X‑ray photons in the vascular and extracellular compartments. After intravenous administration, it distributes rapidly throughout the intravascular space and extracellular fluid, providing high radiodensity that enhances contrast between blood‑filled structures and surrounding tissues during imaging.

Adverse reactions to Optiject may vary in frequency and severity.

Common Side Effects

• Warm sensation or flushing: mild, transient feeling of heat.
• Nausea or vomiting: occasional gastrointestinal upset.
• Headache: mild to moderate intensity.
• Metallic taste: brief alteration of taste perception.
• Injection site discomfort: mild pain or irritation at the site of administration.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rapid onset of airway swelling, hypotension, or urticaria.
• Contrast‑induced nephropathy: acute decline in renal function, particularly in at‑risk patients.
• Cardiovascular collapse: sudden drop in blood pressure or arrhythmia.
• Pulmonary edema: fluid accumulation in the lungs causing breathing difficulty.
• Seizures: rare neurologic events linked to severe hypersensitivity.

When using Optiject, clinicians should assess patient history and monitor for reactions throughout the procedure.

• Renal impairment: evaluate kidney function and consider alternative agents if severe.
• History of iodine allergy: perform allergy testing or choose a non‑iodinated contrast medium.
• Thyroid disorders: monitor thyroid function in patients with hyperthyroidism.
• Cardiovascular disease: observe hemodynamic status during injection.
• Pregnancy and lactation: use only if the diagnostic benefit outweighs potential fetal risk.
• Store at below 25°C: keep in the original container, protect from light and moisture.

Optiject may interact with other medications or substances that affect renal function or hypersensitivity risk.

Major Interactions (Avoid)

• Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): combined use can worsen kidney injury.
• Metformin: risk of lactic acidosis if renal function declines after contrast exposure.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask tachycardia that signals an allergic reaction.
• ACE inhibitors/ARBs: can potentiate contrast‑induced nephropathy; monitor creatinine.
• Diuretics: may affect fluid balance and renal clearance of the contrast.
• NSAIDs: increase risk of renal impairment when used with contrast media.